Thymosin Alpha-1
Also known as: Tα1, Thymalfasin, Zadaxin
By GLPeptideSciences Editorial Team · How we evaluate evidence · Reviewed by Dr. George S. Watson, MD, Cardiothoracic Surgeon · Updated 2026-06-02
An immune-modulating peptide naturally produced by the thymus; an approved drug (thymalfasin / Zadaxin) in a number of countries for specific clinical indications.
What it is & how it works
What it is
Thymosin alpha-1 is a peptide naturally produced by the thymus, the gland central to T-cell immunity. As a manufactured drug (thymalfasin, brand Zadaxin) it is approved in several countries for specific clinical uses.
How it works
Thymosin alpha-1 acts as an immune modulator, influencing T-cell maturation and innate immune signaling (including toll-like receptor pathways). This is the basis for its approved use as an adjunct in certain infections and vaccination contexts.
Evidence and the indication line
This compound has genuine human clinical data — but that data is tied to specific approved indications in the countries where it’s registered. The leap from “approved adjunct therapy” to “general immune booster for healthy people” is not supported by that same evidence, and in the US it is not FDA-approved for general use.
What it's discussed & studied for
- Immune modulation
- Adjunct in specific infections and vaccination contexts (where approved)
Discussion of a use is not a claim that it works or is approved.
Research status
Approved in several countries (as thymalfasin) for defined indications; human clinical literature exists. Not FDA-approved in the US for general use.
Evidence quality
Mixed-to-reasonable for approved indications, with human clinical data; general 'immune-boosting' community use is less rigorously supported.
Dosing discussion
Approved use follows region-specific clinical protocols. Community immune-support dosing outside those indications is not validated guidance.
Educational summary of what is discussed in the literature and community — not a dosing recommendation or medical advice.
Safety & harm reduction
Generally reported as well tolerated in clinical use, with region-specific labeling. Unapproved product bypasses that clinical framework. Not FDA-approved in the US.
Sourcing literacy
An approved pharmaceutical version exists in some markets; gray-market peptide carries identity/purity/sterility risk and no clinical oversight.
Selected literature
FAQ
Is thymosin alpha-1 a real drug?
Yes — as thymalfasin (Zadaxin) it is approved in a number of countries for specific indications, with human clinical data. It is not FDA-approved in the US for general use.
Does it 'boost immunity' for healthy people?
Its evidence is tied to specific clinical indications. General immune-boosting use in healthy people is not what the approval-grade data addresses.